Johns Hopkins Opens New Center for Psychedelic Res
Post# of 85484
https://www.nytimes.com/2019/09/04/science/ps...ssion.html
Wondering if medicinal cannabis, CBD ect may tie into this new research center.
With UNVC having 'ties' with John Hopkins through Mr. Grant (former VP at John Hopkins) and just newly appointed to UNVC's Board of Directors...hmmmm.
Interesting statements from article:
“The one that’s crying out to be done is for opiate-use disorder, and we also plan to look at that,” Dr. Griffiths said.
Trials using psychedelics or other mind-altering drugs tend to have a similar structure. Participants, whether they have a diagnosis of PTSD, depression or substance abuse, do extensive preparation with a therapist, which includes a complete medical history and advice and information about the study drug. People with a history of psychosis are typically excluded, as psychedelics can exacerbate their condition. And those on psychiatric medications usually taper off beforehand.